Yüklüyor......
Novel Oral Anticoagulants for Venous Thromboembolism with Special Emphasis on Risk of Hemorrhagic Complications and Reversal Agents
Warfarin was the only oral anticoagulant available for the treatment of venous thromboembolism for about half a century until the recent approval of novel oral agents dabigatran, rivoraxaban and apixaban. This presents new classes of medications less cumbersome to use. They do not require frequent l...
Kaydedildi:
| Yayımlandı: | Curr Drug ther |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Bentham Science Publishers
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5003057/ https://ncbi.nlm.nih.gov/pubmed/27594818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1574885511666160421145036 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|